Tolvaptan
Indication
Treatment of SIADH for patients not requiring chemotherapy
Grey
Brand:
Samsca
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Endocrine system
Background
Recommendation
LSCMMG Recommendation:
Grey
Reason for decision:
Prioritised for review
Supporting documents: